Top 10 Pharmaceuticals markets in AustraliaThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in Australia, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $443 Mn | $4.6 Bn | 26.4% | 16 |
| 2 | Cell Based Immunotherapy | $199 Mn | $1.8 Bn | 24.5% | 1,080 |
| 3 | Cannabidiol (CBD) | $265 Mn | $1.4 Bn | 18.3% | 3 |
| 4 | Cannabis | $407 Mn | $1.6 Bn | 15% | 9 |
| 5 | Atopic Dermatitis Drugs | $135 Mn | $487 Mn | 13.7% | 28 |
| 6 | Oncology/Cancer Drugs | $2.1 Bn | $5.5 Bn | 9.9% | 1,425 |
| 7 | Anti-Aging | $1.1 Bn | $2.6 Bn | 9.6% | 25 |
| 8 | Diabetes Management | $936 Mn | $2.1 Bn | 8.6% | 83 |
| 9 | Alzheimer Drugs | $60 Mn | $133 Mn | 8.3% | 44 |
| 10 | Contraceptives Drugs | $302 Mn | $671 Mn | 8.3% | 1 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $2.1 Bn | $5.5 Bn | 9.9% | 1,425 |
| 2 | Anti-Aging | $1.1 Bn | $2.6 Bn | 9.6% | 25 |
| 3 | Diabetes Management | $936 Mn | $2.1 Bn | 8.6% | 83 |
| 4 | Gastrointestinal Drugs | $648 Mn | $1.2 Bn | 6.1% | 340 |
| 5 | Asthma & COPD Drugs | $594 Mn | $1 Bn | 5.5% | 29 |
| 6 | Biosimilars | $443 Mn | $4.6 Bn | 26.4% | 16 |
| 7 | Cannabis | $407 Mn | $1.6 Bn | 15% | 9 |
| 8 | HIV Drugs | $360 Mn | $728 Mn | 7.3% | 21 |
| 9 | Contraceptives Drugs | $302 Mn | $671 Mn | 8.3% | 1 |
| 10 | Cancer Supportive Care Drugs | $298 Mn | $543 Mn | 6.2% | 162 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 26.4% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (24.5%).
Oncology/Cancer Drugs is the largest, worth about $2.1 Bn in 2023 and $5.5 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
China
India
Japan
Hong Kong
Philippines
Singapore
Thailand
Malaysia